Clinical Trial Update: IL-2 for Multi Drug Resistant Nephrotic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating interleukin-2 for multi-drug resistant nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Istituto Giannina Gaslini | Conditions: Nephrotic Syndrome | Phase 1, Phase 2 | Status: COMPLETED